Other Issues:		[Index by Author]
Contents:	Volume 27, Issue 32 November 10, 2009

	EDITORIALS
	COMMENTS AND CONTROVERSIES
	ORIGINAL REPORTS
	Breast Cancer
	Gynecologic Cancer
	Pediatric Oncology
	Treatment-Related Complications
	Supportive Care
	Gastrointestinal Cancer
	Hematologic Malignancies
	Genitourinary Cancer
	Melanoma
	REVIEW ARTICLE
	ASCO SPECIAL ARTICLE
	SPECIAL ARTICLE
	DIAGNOSIS IN ONCOLOGY
	CORRESPONDENCE

Find articles in this issue containing these words: [Search ALL Issues]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

                                      EDITORIALS

Could Modification of Lifestyle Factors Prevent Second Primary Breast Cancers? Jennifer A. Ligibel JCO Nov 2009: 5301–5302. First published on Sep 8 2009; 10.1200/JCO.2009.24.4517. [Full Text] [PDF]

Clinical Dilemma of Ductal Carcinoma in Situ Jay R. Harris and Monica Morrow JCO Nov 2009: 5303–5305. First published on Oct 13 2009; 10.1200/JCO.2009.24.1489. [Full Text] [PDF]

Is It Safe to Treat Endometrial Carcinoma Endoscopically? Ignace Vergote, Frederic Amant, and Patrick Neven JCO Nov 2009: 5305–5307. First published on Oct 5 2009; 10.1200/JCO.2009.23.9822. [Full Text] [PDF]

                                      COMMENTS AND CONTROVERSIES

Qualitative Age Interactions in Breast Cancer Studies: Mind the Gap William F. Anderson, Ismail Jatoi, and Mark E. Sherman JCO Nov 2009: 5308–5311. First published on Oct 13 2009; 10.1200/JCO.2009.22.9450. [Full Text] [PDF]

                                      ORIGINAL REPORTS
Breast Cancer

Relationship Between Potentially Modifiable Lifestyle Factors and Risk of Second Primary Contralateral Breast Cancer Among Women Diagnosed With Estrogen Receptor–Positive Invasive Breast Cancer Christopher I. Li, Janet R. Daling, Peggy L. Porter, Mei-Tzu C. Tang, and Kathleen E. Malone JCO Nov 2009: 5312–5318. First published on Sep 8 2009; 10.1200/JCO.2009.23.1597. [Abstract] [Full Text] [PDF]

Local Excision Alone Without Irradiation for Ductal Carcinoma In Situ of the Breast: A Trial of the Eastern Cooperative Oncology Group Lorie L. Hughes, Molin Wang, David L. Page, Robert Gray, Lawrence J. Solin, Nancy E. Davidson, Mary Ann Lowen, James N. Ingle, Abram Recht, and William C. Wood JCO Nov 2009: 5319–5324. First published on Oct 13 2009; 10.1200/JCO.2009.21.8560. [Abstract] [Full Text] [PDF]

Racial and Ethnic Disparities in the Use of Postmastectomy Breast Reconstruction: Results From a Population- Based Study Amy K. Alderman, Sarah T. Hawley, Nancy K. Janz, Mahasin S. Mujahid, Monica Morrow, Ann S. Hamilton, John J. Graff, and Steven J. Katz JCO Nov 2009: 5325–5330. First published on Oct 5 2009; 10.1200/JCO.2009.22.2455. [Abstract] [Full Text] [PDF]

Gynecologic Cancer

Laparoscopy Compared With Laparotomy for Comprehensive Surgical Staging of Uterine Cancer: Gynecologic Oncology Group Study LAP2 Joan L. Walker, Marion R. Piedmonte, Nick M. Spirtos, Scott M. Eisenkop, John B. Schlaerth, Robert S. Mannel, Gregory Spiegel, Richard Barakat, Michael L. Pearl, and Sudarshan K. Sharma JCO Nov 2009: 5331–5336. First published on Oct 5 2009; 10.1200/JCO.2009.22.3248. [Abstract] [Full Text] [PDF]

Quality of Life of Patients With Endometrial Cancer Undergoing Laparoscopic International Federation of Gynecology and Obstetrics Staging Compared With Laparotomy: A Gynecologic Oncology Group Study Alice B. Kornblith, Helen Q. Huang, Joan L. Walker, Nick M. Spirtos, Jacob Rotmensch, and David Cella JCO Nov 2009: 5337–5342. First published on Oct 5 2009; 10.1200/JCO.2009.22.3529. [Abstract] [Full Text] [PDF]

Pediatric Oncology

Comparison of Iodine-123 Metaiodobenzylguanidine (MIBG) Scan and [18F]Fluorodeoxyglucose Positron Emission Tomography to Evaluate Response After Iodine-131 MIBG Therapy for Relapsed Neuroblastoma Denah R. Taggart, Myo M. Han, Alekist Quach, Susan Groshen, Wei Ye, Judith G. Villablanca, Hollie A. Jackson, Carina Mari Aparici, David Carlson, John Maris, Randall Hawkins, and Katherine K. Matthay JCO Nov 2009: 5343–5349. First published on Oct 5 2009; 10.1200/JCO.2008.20.5732. [Abstract] [Full Text] [PDF]

Long-Term Evaluation of Ifosfamide-Related Nephrotoxicity in Children Odile Oberlin, Oumaya Fawaz, Annie Rey, Patrick Niaudet, Vita Ridola, Daniel Orbach, Christophe Bergeron, Annie Sophie Defachelles, Jean-Claude Gentet, Claudine Schmitt, Hervé Rubie, Martine Munzer, Dominique Plantaz, Anne Deville, Veronique Minard, Nadège Corradini, Guy Leverger, and Florent de Vathaire JCO Nov 2009: 5350–5355. First published on Oct 13 2009; 10.1200/JCO.2008.17.5257. [Abstract] [Full Text] [PDF]

Treatment-Related Complications

Longitudinal Cohort Study of Risk Factors in Cancer Patients of Bisphosphonate-Related Osteonecrosis of the Jaw Konstantinos Vahtsevanos, Athanassios Kyrgidis, Evgenia Verrou, Eirini Katodritou, Stefanos Triaridis, Charalampos G. Andreadis, Ioannis Boukovinas, Georgios E. Koloutsos, Zisis Teleioudis, Kyriaki Kitikidou, Panagiotis Paraskevopoulos, Konstantinos Zervas, and Konstantinos Antoniades JCO Nov 2009: 5356–5362. First published on Oct 5 2009; 10.1200/JCO.2009.21.9584. [Abstract] [Full Text] [PDF]

Supportive Care

Phase III Trial of Casopitant, a Novel Neurokinin-1 Receptor Antagonist, for the Prevention of Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy Jørn Herrstedt, Wichit Apornwirat, Ahmed Shaharyar, Zeba Aziz, Fausto Roila, Simon Van Belle, Mark W. Russo, Jeremey Levin, Salabha Ranganathan, Mary Guckert, and Steven M. Grunberg JCO Nov 2009: 5363–5369. First published on Oct 5 2009; 10.1200/JCO.2009.21.8511. [Abstract] [Full Text] [PDF]

Gastrointestinal Cancer

Costs and Cost Effectiveness of a Health Care Provider–Directed Intervention to Promote Colorectal Cancer Screening Veena Shankaran, Thanh Ha Luu, Narissa Nonzee, Elizabeth Richey, June M. McKoy, Joshua Graff Zivin, Alfred Ashford, Rafael Lantigua, Harold Frucht, Marc Scoppettone, Charles L. Bennett, and Sherri Sheinfeld Gorin JCO Nov 2009: 5370–5375. First published on Oct 13 2009; 10.1200/JCO.2008.20.6458. [Abstract] [Full Text] [PDF]

Hematologic Malignancies

Survival Disparities in Patients With Lymphoma According to Place of Residence and Treatment Provider: A Population-Based Study Fausto R. Loberiza, Jr, Anthony J. Cannon, Dennis D. Weisenburger, Julie M. Vose, Matt J. Moehr, Martin A. Bast, Philip J. Bierman, R. Gregory Bociek, and James O. Armitage JCO Nov 2009: 5376–5382. First published on Sep 14 2009; 10.1200/JCO.2009.22.0038. [Abstract] [Full Text] [PDF]

Cost Effectiveness and Screening Interval of Lipid Screening in Hodgkin's Lymphoma Survivors Aileen B. Chen, Rinaa S. Punglia, Karen M. Kuntz, Peter M. Mauch, and Andrea K. Ng JCO Nov 2009: 5383–5389. First published on Sep 14 2009; 10.1200/JCO.2009.22.8460. [Abstract] [Full Text] [PDF]

Randomized Comparison of the Stanford V Regimen and ABVD in the Treatment of Advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244 Peter J. Hoskin, Lisa Lowry, Alan Horwich, Andrew Jack, Ben Mead, Barry W. Hancock, Paul Smith, Wendi Qian, Philippa Patrick, Bilyana Popova, Andrew Pettitt, David Cunningham, Ruth Pettengell, John Sweetenham, David Linch, and Peter W.M. Johnson JCO Nov 2009: 5390–5396. First published on Sep 8 2009; 10.1200/JCO.2009.23.3239. [Abstract] [Full Text] [PDF]

Daunorubicin Versus Mitoxantrone Versus Idarubicin As Induction and Consolidation Chemotherapy for Adults With Acute Myeloid Leukemia: The EORTC and GIMEMA Groups Study AML-10 Franco Mandelli, Marco Vignetti, Stefan Suciu, Roberto Stasi, Maria-Concetta Petti, Giovanna Meloni, Petra Muus, Filippo Marmont, Jean-Pierre Marie, Boris Labar, Xavier Thomas, Francesco Di Raimondo, Roel Willemze, Vincenzo Liso, Felicetto Ferrara, Liliana Baila, Paola Fazi, Robert Zittoun, Sergio Amadori, and Theo de Witte JCO Nov 2009: 5397–5403. First published on Oct 13 2009; 10.1200/JCO.2008.20.6490. [Abstract] [Full Text] [PDF]

Lenalidomide Oral Monotherapy Produces Durable Responses in Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma Thomas E. Witzig, Peter H. Wiernik, Timothy Moore, Craig Reeder, Craig Cole, Glen Justice, Henry Kaplan, Michael Voralia, Dennis Pietronigro, Kenichi Takeshita, Annette Ervin-Haynes, Jerome B. Zeldis, and Julie M. Vose JCO Nov 2009: 5404–5409. First published on Oct 5 2009; 10.1200/JCO.2008.21.1169. [Abstract] [Full Text] [PDF]

Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma Richard L. Piekarz, Robin Frye, Maria Turner, John J. Wright, Steven L. Allen, Mark H. Kirschbaum, Jasmine Zain, H. Miles Prince, John P. Leonard, Larisa J. Geskin, Craig Reeder, David Joske, William D. Figg, Erin R. Gardner, Seth M. Steinberg, Elaine S. Jaffe, Maryalice Stetler-Stevenson, Stephen Lade, A. Tito Fojo, and Susan E. Bates JCO Nov 2009: 5410–5417. First published on Oct 13 2009; 10.1200/JCO.2008.21.6150. [Abstract] [Full Text] [PDF]

Pegylated Interferon Alfa-2a Yields High Rates of Hematologic and Molecular Response in Patients With Advanced Essential Thrombocythemia and Polycythemia Vera Alfonso Quintás-Cardama, Hagop Kantarjian, Taghi Manshouri, Rajyalakshmi Luthra, Zeev Estrov, Sherry Pierce, Mary Ann Richie, Gautam Borthakur, Marina Konopleva, Jorge Cortes, and Srdan Verstovsek JCO Nov 2009: 5418–5424. First published on Oct 13 2009; 10.1200/JCO.2009.23.6075. [Abstract] [Full Text] [PDF]

Phase II Study of Alemtuzumab in Combination With Pentostatin in Patients With T-Cell Neoplasms Farhad Ravandi, Ahmed Aribi, Susan O'Brien, Stefan Faderl, Dan Jones, Alessandra Ferrajoli, Xuelin Huang, Sergernne York, Sherry Pierce, William Wierda, Dimitrios Kontoyiannis, Srdan Verstovsek, Barbara Pro, Luis Fayad, Michael Keating, and Hagop Kantarjian JCO Nov 2009: 5425–5430. First published on Oct 5 2009; 10.1200/JCO.2009.22.6688. [Abstract] [Full Text] [PDF]

Genitourinary Cancer

Multinational, Double-Blind, Phase III Study of Prednisone and Either Satraplatin or Placebo in Patients With Castrate-Refractory Prostate Cancer Progressing After Prior Chemotherapy: The SPARC Trial Cora N. Sternberg, Daniel P. Petrylak, Oliver Sartor, J. Alfred Witjes, Tomasz Demkow, Jean-Marc Ferrero, Jean-Christophe Eymard, Silvia Falcon, Fabio Calabrò, Nicholas James, Istvan Bodrogi, Peter Harper, Manfred Wirth, William Berry, Michael E. Petrone, Thomas J. McKearn, Mojtaba Noursalehi, Martine George, and Marcel Rozencweig JCO Nov 2009: 5431–5438. First published on Oct 5 2009; 10.1200/JCO.2008.20.1228. [Abstract] [Full Text] [PDF]

Melanoma

Serum 25-Hydroxyvitamin D3 Levels Are Associated With Breslow Thickness at Presentation and Survival From Melanoma Julia A. Newton-Bishop, Samantha Beswick, Juliette Randerson-Moor, Yu-Mei Chang, Paul Affleck, Faye Elliott, May Chan, Susan Leake, Birute Karpavicius, Sue Haynes, Kairen Kukalizch, Linda Whitaker, Sharon Jackson, Edwina Gerry, Clarissa Nolan, Chandra Bertram, Jerry Marsden, David E. Elder, Jennifer H. Barrett, and D. Timothy Bishop JCO Nov 2009: 5439–5444. First published on Sep 21 2009; 10.1200/JCO.2009.22.1135. [Abstract] [Full Text] [PDF]

National Assessment of Melanoma Care Using Formally Developed Quality Indicators Karl Y. Bilimoria, Mehul V. Raval, David J. Bentrem, Jeffrey D. Wayne, Charles M. Balch, and Clifford Y. Ko JCO Nov 2009: 5445–5451. First published on Oct 13 2009; 10.1200/JCO.2008.20.9965. [Abstract] [Full Text] [PDF]

Phase II, Randomized, Controlled, Double-Blinded Trial of Weekly Elesclomol Plus Paclitaxel Versus Paclitaxel Alone for Stage IV Metastatic Melanoma Steven O'Day, Rene Gonzalez, David Lawson, Robert Weber, Laura Hutchins, Clay Anderson, Jonathan Haddad, Steven Kong, Anthony Williams, and Eric Jacobson JCO Nov 2009: 5452–5458. First published on Oct 13 2009; 10.1200/JCO.2008.17.1579. [Abstract] [Full Text] [PDF]

                                      REVIEW ARTICLE

Histone Deacetylase Inhibitors in Cancer Therapy Andrew A. Lane and Bruce A. Chabner JCO Nov 2009: 5459–5468. First published on Oct 13 2009; 10.1200/JCO.2009.22.1291. [Abstract] [Full Text] [PDF]

                                      ASCO SPECIAL ARTICLE

American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards Joseph O. Jacobson, Martha Polovich, Kristen K. McNiff, Kristine B. LeFebvre, Charmaine Cummings, Michele Galioto, Katherine R. Bonelli, and Michele R. McCorkle JCO Nov 2009: 5469–5475. First published on Sep 28 2009; 10.1200/JCO.2009.25.1264. [Abstract] [Full Text] [PDF] [Publisher's Note]

                                      SPECIAL ARTICLE

Improving the Methodologic and Ethical Validity of Best Supportive Care Studies in Oncology: Lessons From a Systematic Review Nathan I. Cherny, Amy P. Abernethy, Florian Strasser, Rama Sapir, David Currow, and S. Yousuf Zafar JCO Nov 2009: 5476–5486. First published on Jun 29 2009; 10.1200/JCO.2009.21.9592. [Abstract] [Full Text] [PDF]

                                      DIAGNOSIS IN ONCOLOGY

Synchronous Advanced Pure Seminoma and Diffuse Large B-Cell Lymphoma: A Case of Multiple Oncologic Dilemmas Michael A. White, Alexander P. DeHaan, J. Michael Wilson, Michael H. Zakem, and Thomas J. Maatman JCO Nov 2009: e181–e183. First published on Sep 21 2009; 10.1200/JCO.2009.22.8551. [Full Text] [PDF]

Coexistence of Leishmaniasis and Hodgkin's Lymphoma in a Lymph Node Mariana Domingues, Yara Menezes, Fabiana Ostronoff, Rodolfo Calixto, Rodrigo Florencio, Alexandre Sucupira, Ana Patricia Souto-Maior, and Mauricio Ostronoff JCO Nov 2009: e184–e185. First published on Oct 5 2009; 10.1200/JCO.2009.22.7835. [Full Text] [PDF]

                                      CORRESPONDENCE

Thalidomide Maintenance in Multiple Myeloma: Certainties and Controversies Michele Cavo, Lucia Pantani, Paola Tacchetti, Maria Caterina Pallotti, Annamaria Brioli, Alessandro Petrucci, Elena Zamagni, and Patrizia Tosi JCO Nov 2009: e186–e187. First published on Sep 21 2009; 10.1200/JCO.2009.24.0150. [Full Text] [PDF] [Publisher's Note]

Reply to M. Cavo Andrew Spencer, H. Miles Prince, and Andrew W. Roberts JCO Nov 2009: e188. First published on Sep 21 2009; 10.1200/JCO.2009.24.0853. [Full Text] [PDF]

Time to Treatment Does Not Influence Overall Survival in Newly Diagnosed Mantle-Cell Lymphoma Heather E. Eve, Michelle V. Furtado, Michael D. Hamon, and Simon A.J. Rule JCO Nov 2009: e189–e190. First published on Oct 5 2009; 10.1200/JCO.2009.23.9731. [Full Text] [PDF]

Reply to H.E. Eve et al Peter Martin and John P. Leonard JCO Nov 2009: e191. First published on Oct 5 2009; 10.1200/JCO.2009.24.0176. [Full Text] [PDF]

What Does the Medical Profession Mean By "Standard of Care?" Dirk C. Strauss and J. Meirion Thomas JCO Nov 2009: e192–e193. First published on Sep 21 2009; 10.1200/JCO.2009.24.6678. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.